New Insights into the Lipophilicity of Ionized Species

Pharmacokinetic Profiling in Drug Research

Volumn , Issue , 2007, Pages 165-185

  Caron, Giulia ^a   Ermondi, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Charged molecules; Ionized molecules; Lipophilicity of ionized species; Neutral molecules; Physicochemical strategies; Unionized molecules

Indexed keywords

MOLECULES;

CHARGED MOLECULE; IONIZED MOLECULES; IONIZED SPECIES; NEUTRAL MOLECULES; PHYSICOCHEMICAL STRATEGIES;

IONIZATION;

EID: 84956630351     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783906390468.ch11     Document Type: Chapter

References (44)

1. G. Plempler van Balen, C. a Marca Martinet, G. Caron, G. Bouchard, M. Reist, P. A. Carrupt, R. Fruttero, A. Gasco, B. Testa, Med. Res. Rev. 2003, 24, 299.
2. A. Avdeef, Absorption and Drug Development. Solubility, Permeability, and Charge State',Wiley, New York, 2003.
3. G. Caron, G. Ermondi, Mini-Rev. Med. Chem. 2003, 3, 821.
4. A. Pagliara, P. A. Carrupt, G. Caron, P. Gaillard, B. Testa, Chem. Rev. 1997, 97, 3385.
5. A. Pagliara, E. Khamis,A.Trinh, P. A. Carrupt, R. S. Tsai,B.Testa, J. Liq. Chromatogr. 1995, 18, 1721.
6. C. A. S. Bergstrçm, M. Strafford, L. Lazorova, A. Avdeef, K. Luthman, P. Artursson, J. Med. Chem. 2003, 46, 558.
7. SIMCA-P, Vers. 10.0.2.0, Umetrics, Umeä, 2003.
8. MOE, Vers. 2002.03, Chemical Computing Group Inc., Montreal, Canada, 2002.
9. G. Ermondi, M. Lorenti, G. Caron, J. Med. Chem. 2004, 47, 3949.
10. G. Colmenarejo,A. Alvarez-Pedraglio, J.-L. Lavandera, J. Med. Chem. 2001, 44, 4370.
11. F. Barbato, M. I. La Rotonda, F. Quaglia, J. Pharm. Sci. 1997, 86, 225.
12. A. Taillardat-Bertschinger, C. a Marca Martinet, P. A. Carrupt, M. Reist,G. Caron, R. Fruttero, B. Testa, Pharm. Res. 2001, 19, 729.
13. M.Amato, F. Barbato, P. Morrica, F. Quaglia, M. I. La Rotonda, Helv. Chim. Acta 2000, 83, 2836.
14. C. Ottiger, H.Wunderli-Allenspach, Pharm. Res. 1999, 16, 643.
15. A.Taillardat-Bertschinger,A. Galland, P. A. Carrupt,B.Testa, J. Chromatogr.,A2002, 953, 39.
16. B. Testa, G. Caron, P. Crivori, S. Rey, M. Reist, P. A. Carrupt, Chimia 2000, 54, 672.
17. B. Testa, P. A. Carrupt, P. Gaillard, R. S. Tsai, in Lipophilicity in Drug Action and Toxicology', Eds. V. Pliska, B. Testa, H. van de Waterbeemd, VCH Publishers, Weinheim, 1996, p. 49-71.
18. M. J. Kamlet, R. W. Taft, J. Am. Chem. Soc. 1976, 98, 377.
19. R. W. Taft, M. J. Kamlet, J. Am. Chem. Soc. 1976, 98, 2886.
20. Absolv, Vers. 1.4.05.63, Sirius Analytical Instruments Ltd., 2000.
21. D. T. Stanton, P. C. Jurs, Anal. Chem. 1990, 62, 2323.
22. Pharmacokinetic Optimization in Drug Research. Biological, Physicochemical, and Computational Strategies', Eds. B. Testa, H. van de Waterbeemd, G. Folkers, R. H. Guy, Verlag Helvetica Chimica Acta, Z'rich, 2001.
23. A.Avdeef, in Lipophilicity in Drug Action andToxicology', Eds.V. Pliska,B. Testa, H. van de Waterbeemd, VCH Publishers,Weinheim, 1996, p. 109-139.
24. F. Reymond,V. Gobry,G. Bouchard, H. H. Girault, in Pharmacokinetic Optimization in Drug Research. Biological, Physicochemical, and Computational Strategies', Eds.B. Testa, H. van deWaterbeemd, G. Folkers, R. H. Guy, Verlag Helvetica Chimica Acta, Z'rich, 2001, p. 327 -349.
25. G. Bouchard, A. Pagliara, P. A. Carrupt,B. Testa,V. Gobry,H. H. Girault, Pharm. Res. 2002, 19, 1150.
26. S. M. Ulmeanu, H. Jensen, G. Bouchard, P. A. Carrupt, H. H. Girault, Pharm. Res. 2003, 20, 1317.
27. H. Kubinyi, QSAR: Hansch Analysis and Related Approaches', VCH Publishers, Weinheim, 1993.
28. G. Bouchard, P. A. Carrupt, B. Testa, V. Gobry, H. H. Girault, Chem.-Eur. J. 2002, 8, 3478.
29. G. Caron, G. Steyaert, A. Pagliara, F. Reymond, P. Crivori, P. Gaillard, P. A. Carrupt, A. Avdeef, J. E. Comer, K. J. Box, H. H. Girault, B. Testa, Helv. Chim. Acta 1999, 82, 1211.
30. V. Chopineaux-Courtois, F. Reymond, G. Bouchard, P. A. Carrupt, B. Testa, H. H. Girault, J. Am. Chem. Soc. 1999, 121, 1743.
31. S. D. Krümer, C. Jakits-Deiser, H. Wunderli-Allenspach, Pharm. Res. 1997, 14, 827.
32. G. V. Betageri, J. A. Rogers, Int. J. Pharm. 1988, 46, 95.
33. G. M. Pauletti, H.Wunderli-Allenspach, Eur. J. Pharm. Sci. 1994, 1, 273.
34. S. D. Krümer, A. Braun, C. Jakits-Deiser, H.Wunderli-Allenspach, Pharm. Res. 1998, 15, 739.
35. L. Herbette, M. Vecchiarelli, A. Leonardi, J. Cardiovasc. Pharmacol. 1997, 29, S19.
36. A. Leonardi, E. Poggesi, C. Taddei, L. Guarnieri, P. Angelico, M. R. Accomazzo, S. Nicosia, R. Testa, J. Cardiovasc. Pharmacol. 1997, 29, S10.
37. U. Franke, A. Munk, M.Wiese, J. Pharm. Sci. 1999, 88, 89.
38. L. Herbette, D. G. Rhodes, R. Preston Mason, Drug Des. Delivery 1991, 7, 75.
39. V. Zia, R. A. Rajewski, V. J. Stella, Pharm. Res. 2001, 18, 667.
40. A. Nasal, D. Siluk, R. Kaliszan, Cur. Med. Chem. 2003, 10, 381.
41. F. Barbato, M. I. La Rotonda, F. Quaglia, Eur. J. Med. Chem. 1996, 31, 311.
42. L. H. Alifrangis, I. T. Christensen, A. Berglund, M. Sandberg, L. Hovgaard, S. Frokjaer, J. Med. Chem. 2000, 43, 103.
43. R. Kaliszan, A. Nasal, A. Bucinski, Eur. J. Med. Chem. 1994, 29, 163.
44. A. Taillardat-Bertschinger, P. A. Carrupt, F. Barbato, B. Testa, J. Med. Chem. 2003, 46, 655.